Company Renames to TAKE LIMITED, Pivots to Healthcare & Pharma

TAKE Solutions Ltd is seeking shareholder approval to rename the company TAKE LIMITED. This move signals a strategic shift towards healthcare and digital health sectors. The e-voting period for this proposed transformation runs from May 18 to June 16, 2026.

Key Proposals for Shareholders

TAKE Solutions Limited has begun the process to gain shareholder consent for significant corporate changes. These include the proposed renaming to TAKE LIMITED.

The company also plans to expand its business into the healthcare, pharmaceuticals, life sciences, and digital health sectors. These expansions require amendments to its Memorandum of Association (MOA).

Shareholders will also vote on appointing M/s. A. Raghavendra Rao & Associates as new statutory auditors to fill a casual vacancy.

Strategic Shift to Health Sectors

This rebranding and expansion marks a strategic diversification for TAKE Solutions, aiming to capture growth opportunities in high-potential areas like healthcare and digital health. The name change reflects a move toward a stronger, future-focused brand identity.

Existing IT Capabilities in Life Sciences

TAKE Solutions has established IT services capabilities, including a presence in healthcare and life sciences. The company has a history of providing IT solutions in supply chain management and analytics, with increasing focus on life sciences IT such as clinical trials and regulatory compliance.

This proposed expansion deepens its commitment by leveraging existing expertise and technology to meet growing market demand.

Impact of Shareholder Approval

If shareholders approve, the company will operate as TAKE LIMITED, reflecting a refreshed corporate identity.

The expanded business scope will allow the company to pursue opportunities in healthcare, pharmaceuticals, and digital health segments.

New statutory auditors will be appointed as per regulatory procedures.

Potential Challenges Ahead

Executing this diversification strategy into complex sectors like pharmaceuticals and healthcare involves significant operational and market entry risks.

Shareholder approval is required, and failure to secure it could halt these proposed changes.

Navigating the complex regulatory environments in healthcare and pharmaceuticals requires specialized expertise and compliance.

Competitive Landscape

Major Indian IT firms like Infosys and TCS have already established strong healthcare and life sciences divisions.

These companies use their IT expertise to provide data analytics, cloud services, and digital transformation for the healthcare sector.

TAKE Solutions aims to establish its own niche by focusing more deeply on these technology-driven health areas.

Looking Ahead: What Investors Should Monitor

Monitor the results of the postal ballot and e-voting process for shareholder approval.

Follow future announcements on the formal adoption of the new name and business objectives.

Look for strategic partnerships, new services, or investments in the healthcare, pharmaceuticals, and digital health sectors.